Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03402477
What this trial is testing

"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Helse Stavanger HF 86
Testing effectiveness (Phase 2)Study completedNCT01949701
What this trial is testing

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shiga University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439201
What this trial is testing

Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+2 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Early research (Phase 1)Ended earlyNCT04865419
What this trial is testing

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Who this might be right for
Haematological Malignancies
AstraZeneca 46
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)Looking for participantsNCT07494565
What this trial is testing

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)CD5 Positive
Sun Yat-sen University 60
Early research (Phase 1)Study completedNCT02157792
What this trial is testing

M6620 First in Human Study

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 200
Very early researchUnknownNCT03863145
What this trial is testing

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Who this might be right for
Advanced Refractory Solid TumorsSubjects Considered Likely to Respond to CB-03-10
Cosmo Technologies Ltd 90
Early research (Phase 1)Ended earlyNCT01252095
What this trial is testing

Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Zucero Pty Ltd 4
Not applicableStudy completedNCT03316157
What this trial is testing

Exercise and Nutritional Rehabilitation in Patients With Cancer

Who this might be right for
Cachexia; CancerDiet ModificationPhysical Activity+1 more
University of Edinburgh 45
Testing effectiveness (Phase 2)UnknownNCT04467801
What this trial is testing

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Jun Zhang, MD, PhD 60
Early research (Phase 1)Ended earlyNCT05501912
What this trial is testing

ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Shanghai Company Limited 20
Not applicableStudy completedNCT03911219
What this trial is testing

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Who this might be right for
Stage IV Non-small Cell Lung CancerExtensive-stage Small Cell Lung CancerAdvanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
iOMEDICO AG 154
Very early researchLooking for participantsNCT06150365
What this trial is testing

Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

Who this might be right for
Refractory Solid TumorsRelapsed Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 12
Not applicableUnknownNCT05490667
What this trial is testing

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Who this might be right for
Desmoid
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01100931
What this trial is testing

A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)

Who this might be right for
NSCLCSolid Tumors
National Cancer Institute (NCI) 42
Early research (Phase 1)UnknownNCT04477057
What this trial is testing

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT00996957
What this trial is testing

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Advanced Solid TumorsMultiple Myeloma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 37
Testing effectiveness (Phase 2)Looking for participantsNCT05323201
What this trial is testing

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Hospital of Xuzhou Medical University 15
Next Page